Answers are grounded in this paper and cite their sources.
This appraisal evaluates WHO’s new tuberculosis diagnostics in high-burden populations, suggesting further evidence is needed.
Recently, the World Health Organization (WHO) endorsed three new diagnostic strategies for tuberculosis (TB): Near-point-of-care nucleic acid amplification tests (NPOC-NAATs), tongue swabs as an alternative to sputum, and pooled sputum testing. Each addresses real barriers to case detection in high-burden settings. However, the supporting evidence for each remains thin precisely in the populations where the diagnostic gap is widest: children, people living with HIV (PLHIV), and patients with extrapulmonary or paucibacillary disease. We argue that these recommendations should be viewed as the start of an evidence-generation cycle rather than its endpoint and propose four concrete safeguards before unrestricted programmatic scale-up.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: